Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Limited announced a change in the director’s interest, with Adam Davey converting 566,572 performance rights into fully paid ordinary shares. This adjustment reflects a strategic move in the company’s governance and may influence stakeholder perceptions regarding the company’s management and future direction.
More about PainChek Ltd
PainChek Limited operates in the healthcare technology industry, specializing in the development of pain assessment tools. Their primary product is a smartphone-based application that uses artificial intelligence to assess and manage pain, particularly in non-verbal patients. The company focuses on improving patient care and outcomes in both clinical and home settings.
Average Trading Volume: 1,939,781
Technical Sentiment Signal: Buy
Current Market Cap: A$107.3M
For a thorough assessment of PCK stock, go to TipRanks’ Stock Analysis page.